(Q68773103)
Statements
Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study (English)
Atzpodien J
Körfer A
Evers P
Franks CR
Knüver-Hopf J
Lopez-Hänninen E
Fischer M
Mohr H
Dallmann I
1 March 1990